Related Experiment Video
Updated: Mar 7, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Cardiovascular disease in Africa: epidemiological profile and challenges
Ashley K Keates1, Ana O Mocumbi2, Mpiko Ntsekhe3
1Mary MacKillop Institute for Health Research, Australian Catholic University, Level 5, 215 Spring Street, Melbourne, Victoria 3000, Australia.
Insights
Cardiovascular disease (CVD) disproportionately affects Africa. Rising noncommunicable CVD risk from hypertension, smoking, and obesity, alongside existing diseases, demands better data for effective public health strategies.
Area of Science:
- Public Health
- Epidemiology
- Cardiology
Background:
- Cardiovascular disease (CVD) poses a significant and growing health challenge in Africa.
- The continent's diverse populations experience a complex interplay of communicable and noncommunicable disease pathways leading to CVD.
- Factors like hypertension, smoking, and obesity are increasing the risk of noncommunicable CVD.
Purpose of the Study:
- To present a contemporary overview of cardiovascular disease epidemiology in Africa.
- To identify and discuss regional disparities in CVD prevalence and risk factors.
- To highlight knowledge gaps in understanding the full burden of CVD across African populations.
Main Methods:
- Review of existing epidemiological data and literature on cardiovascular disease in Africa.
- Analysis of regional variations in CVD incidence, risk factors, and disease types.
- Synthesis of current knowledge and identification of areas requiring further research.
Main Results:
- Cardiovascular disease disproportionately impacts the large and diverse African population.
- Future CVD burden is expected to rise due to increasing rates of hypertension, smoking, and obesity.
- Both historically prevalent (e.g., rheumatic heart disease) and emerging CVDs (e.g., coronary artery disease) are significant concerns.
Conclusions:
- Accurate and current epidemiological data are crucial for developing effective CVD reduction strategies in Africa.
- Addressing the evolving CVD burden requires understanding regional differences and knowledge gaps.
- There is an urgent need for comprehensive data to combat the increasing prevalence of cardiovascular disease across the continent.
Abstract:
From a global perspective, the large and diverse African population is disproportionately affected by cardiovascular disease (CVD). The historical balance between communicable and noncommunicable pathways to CVD in different African regions is dependent on external factors over the life course and at a societal level. The future risk of noncommunicable forms of CVD (predominantly driven by increased rates of hypertension, smoking, and obesity) is a growing public health concern. The incidence of previously rare forms of CVD such as coronary artery disease will increase, in concert with historically prevalent forms of disease, such as rheumatic heart disease, that are yet to be optimally prevented or treated. The success of any strategies designed to reduce the evolving and increasing burden of CVD across the heterogeneous communities living on the African continent will be dependent upon accurate and up-to-date epidemiological data on the cardiovascular profile of every major populace and region. In this Review, we provide a contemporary picture of the epidemiology of CVD in Africa, highlight key regional discrepancies among populations, and emphasize what is currently known and, more importantly, what is still unknown about the CVD burden among the >1 billion people living on the continent.
More Related Videos
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease I: Introduction
Cardiovascular Drugs: Classification based on Therapeutic Indications
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

